BCBruna Therly Ferreira Cunha

Bruna Therly Ferreira Cunha

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Bruna Therly Ferreira Cunha has a total of 6 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Thymomodulin as an Immunomodulatory Agent in Animal Species: a Scoping Review on Animal Health Impacts, One Health Interfaces, and Translational Relevance

    by Marilu Swiech, Ketllin Bragnholo, Bruna Therly Ferreira Cunha, Jessica Mendes Nadal, Paulo Vitor Farago, Bill Jorge Costa, Guilherme dos Anjos Camargo

    Thymomodulin is a thymus-derived peptide preparation with immunomodulatory properties studied in experimental and veterinary contexts. Within a One Health framework, integrating animal, human, and environmental health, enhancing animal immunity is hypothesized to aid disease prevention, reduce zoonotic transmission, and decrease antimicrobial use. This scoping review mapped evidence on thymomodulin and comparable calf thymus extracts as immunomodulators in non-human animals from 2000 to 2025, evaluating their relevance for One Health strategies. A structured literature search (1 January 2000-31 December 2025) was conducted in PubMed, Scopus, Web of Science, and SciELO, supplemented by grey literature and patent searches. Peer-reviewed studies reporting immunological or clinical outcomes in non-human animals were included; human-only studies and those lacking immune or health endpoints were excluded. Across species, thymomodulin consistently modulated innate and adaptive immunity. In fish, dietary supplementation enhanced vaccine responsiveness, antibody titers, and survival after pathogen challenge. In rodents, thymomodulin restored immune function in immunosuppressed models and accelerated pathogen clearance. In companion animals, adjunct therapy improved clinical outcomes, including increased survival and faster remission in cats with disseminated sporotrichosis, as well as improved hematological parameters in immunocompromised animals. Evidence from poultry and swine suggests enhanced vaccine-induced immunity and maternal transfer of immune protection. Overall, thymomodulin acts as an immune normalizer, reinforcing host defenses under immune compromise. These immunological benefits could potentially reduce pathogen shedding and the need for antimicrobials indirectly; however, the evidence remains heterogeneous. Standardized clinical trials and field-based studies are needed to support translation into One Health practice.